UK markets closed
  • FTSE 100

    7,556.23
    -2.26 (-0.03%)
     
  • FTSE 250

    19,363.28
    -46.12 (-0.24%)
     
  • AIM

    853.32
    +2.76 (+0.32%)
     
  • GBP/EUR

    1.1651
    +0.0008 (+0.07%)
     
  • GBP/USD

    1.2285
    +0.0028 (+0.23%)
     
  • BTC-GBP

    13,932.43
    +96.88 (+0.70%)
     
  • CMC Crypto 200

    404.33
    +2.91 (+0.72%)
     
  • S&P 500

    4,071.70
    -4.87 (-0.12%)
     
  • DOW

    34,429.88
    +34.88 (+0.10%)
     
  • CRUDE OIL

    80.34
    +0.36 (+0.45%)
     
  • GOLD FUTURES

    1,797.30
    +1.40 (+0.08%)
     
  • NIKKEI 225

    27,777.90
    -448.20 (-1.59%)
     
  • HANG SENG

    18,675.35
    -61.05 (-0.33%)
     
  • DAX

    14,529.39
    +39.09 (+0.27%)
     
  • CAC 40

    6,742.25
    -11.72 (-0.17%)
     

Aquis Stock Exchange: Admission to trading on the AQSE Growth Market

Aquis Stock Exchange
Aquis Stock Exchange: Admission to trading on the AQSE Growth Market
14-Nov-2022 / 07:00 GMT/BST

EDX MEDICAL GROUP PLC

The following securities are re-admitted to trading on the AQSE Growth Market with effect from 08:00 on 14/11/2022 following a reverse takeover:

Name of issuer: EDX Medical Group Plc (previously TECC Capital Plc)

Securities: Ordinary Shares

ISIN: GB00BNDMJS47

Symbol: EDX

The Regulation Department

Aquis Stock Exchange

Floor 2, 63 Queen Victoria Street, EC4N 4UA

Tel: 0203 597 6361

Email: aqseregulation@aquis.eu
Website: www.aquis.eu/aquis-stock-exchange


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

End of Announcement - EQS News Service

show this
show this